Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR-Ab ...

Myasthenia gravis is an autoimmune condition that weakens the muscles in your body. Acetylcholine is a neurotransmitter that helps your muscles move. Most people with generalized myasthenia gravis ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major ...

Ocular MG is a milder form of generalized MG, with lower AChR titers and less aggressive treatment needs. AChR titers above 100 nmol/L at diagnosis predict progression from ocular to generalized MG.

Treatment with efgartigimod IV was associated with a statistically significant and clinically meaningful improvement in MG-ADL total score compared with placebo. Topline results were announced from a ...

Myasthenia gravis is a life-long (chronic) autoimmune condition, which means that the body’s immune system attacks its own healthy cells. Most people with generalized myasthenia gravis (gMG) have ...

Three agents are approved, and more studies are underway ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

Autoimmune Autonomic Ganglionopathy (AAG) is a rare, immunologically mediated disorder characterised by dysfunction of the autonomic nervous system. The condition arises when autoantibodies, ...